Cleared Traditional

K072575 - TRIATHLON SCREW-FIXATION TIBIAL BASEPLATE

K072575 is an FDA 510(k) clearance for TRIATHLON SCREW-FIXATION TIBIAL BASEPLATE, manufactured by Stryker Orthopaedics. The device is a Class 2 Orthopedic device with product code MBH cleared through the Traditional 510(k) pathway after a 116-day FDA review.

K072575 · Stryker Orthopaedics · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
116d
Days
Class 2
Risk

K072575 is an FDA 510(k) clearance for the TRIATHLON SCREW-FIXATION TIBIAL BASEPLATE. Classified as Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer (product code MBH), Class II - Special Controls.

Submitted by Stryker Orthopaedics (Mahwah, US). The FDA issued a Cleared decision on January 7, 2008 after a review of 116 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3565 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Orthopaedics devices

FDA 510(k) Submission Details - K072575

510(k) Number K072575 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2007
Decision Date January 07, 2008
Days to Decision 116 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 122d · This submission: 116d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MBH Device Classification - Class 2, Special Controls

Product Code MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3565
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MBH Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer

All 130
Devices cleared under the same product code (MBH) and FDA review panel - the closest regulatory comparables to K072575.
REGENEREX PATELLA COMPONENTS
K083782 · Biomet Manufacturing Corp · Apr 2009
ADVANCE A-CLASS TIBIAL INSERT
K081479 · Wrightmedicaltechnologyinc · Feb 2009
REGENEREX TIBIAL COMPONENTS
K080361 · Biomet, Inc. · Apr 2008
LEGION POROUS PRIMARY
K073325 · Smith & Nephew, Inc. · Dec 2007
NEXGEN COMPLETE KNEE SOLUTION LPS-FLEX AND KNEE GENDER SOLUTIONS FEMALE (GSF) POROUS FEMORAL COMPONENTS
K072619 · Zimmer, Inc. · Nov 2007
NEXGEN TRABECULAR METAL TIBIAL TRAY
K072160 · Zimmer, Inc. · Sep 2007